bf/NASDAQ:CSBR_icon.jpeg

NASDAQ:CSBR

Champions Oncology

  • Stock

USD

Last Close

6.88

06/11 21:00

Market Cap

69.87M

Beta: 0.87

Volume Today

70.65K

Avg: 10.77K

PE Ratio

−8.40

PFCF: −16.74

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Apr '15
Apr '16
Apr '17
Apr '18
Apr '19
Apr '20
Apr '21
Apr '22
Apr '23
Apr '24
Apr '25
revenue
8.86M
-
11.18M
26.16%
15.41M
37.82%
20.24M
31.34%
27.07M
33.72%
32.12M
18.68%
41.04M
27.76%
49.11M
19.66%
53.87M
9.69%
50.16M
6.90%
cost of revenue
7.63M
-
8.69M
13.80%
9.70M
11.71%
10.55M
8.76%
14.27M
35.17%
16.88M
18.35%
21.47M
27.20%
23.63M
10.05%
29.53M
24.97%
29.40M
0.44%
28.39M
3.44%
gross profit
1.23M
-
2.50M
102.93%
5.71M
128.69%
9.69M
69.73%
12.80M
32.14%
15.24M
19.05%
19.57M
28.38%
25.48M
30.21%
24.34M
4.47%
20.75M
14.73%
-28.39M
236.79%
selling and marketing expenses
4.28M
-
3.44M
19.57%
3.26M
5.34%
2.57M
21.19%
3.06M
18.91%
4.24M
38.81%
5.52M
30.13%
6.38M
15.56%
7.00M
9.77%
7.06M
0.89%
7.54M
6.81%
general and administrative expenses
5.34M
-
5.17M
3.13%
4.96M
4.06%
4.07M
17.97%
4.68M
14.91%
6.61M
41.39%
6.51M
1.54%
9.12M
40.00%
10.24M
12.32%
11.07M
8.08%
9.34M
15.61%
selling general and administrative expenses
9.62M
-
8.62M
10.44%
8.22M
4.57%
6.64M
19.25%
7.73M
16.46%
10.86M
40.37%
12.03M
10.83%
15.50M
28.79%
17.24M
11.27%
18.13M
5.16%
16.88M
6.88%
research and development expenses
4.84M
-
4.19M
13.44%
4.29M
2.36%
4.40M
2.52%
4.80M
9.02%
5.85M
21.99%
7.20M
22.95%
9.37M
30.27%
11.54M
23.16%
9.54M
17.33%
6.83M
28.49%
other expenses
225K
-
-38K
116.89%
-56K
47.37%
-88K
57.14%
-39K
55.68%
-42K
7.69%
71K
269.05%
-24K
133.80%
-11K
54.17%
48K
536.36%
293K
510.42%
cost and expenses
22.10M
-
21.50M
2.73%
22.22M
3.36%
21.59M
2.81%
26.80M
24.09%
33.59M
25.35%
40.70M
21.17%
48.50M
19.16%
58.32M
20.24%
57.08M
2.13%
52.39M
8.21%
operating expenses
14.47M
-
12.81M
11.45%
12.52M
2.30%
11.04M
11.78%
12.53M
13.49%
16.71M
33.33%
19.23M
15.08%
24.87M
29.34%
28.79M
15.75%
27.68M
3.86%
24.00M
13.27%
interest expense
39K
-
24K
-
ebitda
-13.02M
-
-10.16M
21.99%
-6.64M
34.64%
-994K
85.03%
876K
188.13%
-308K
135.16%
1.52M
594.16%
2.23M
46.78%
-1.40M
162.49%
-5.05M
262.03%
4.55M
190.09%
operating income
-13.24M
-
-10.32M
22.07%
-6.81M
34.00%
-1.35M
80.11%
270K
119.94%
-1.47M
643.70%
338K
123.02%
607K
79.59%
-4.45M
832.95%
-6.92M
55.56%
4.55M
165.79%
depreciation and amortization
214K
-
156K
27.10%
168K
7.69%
360K
114.29%
606K
68.33%
1.16M
91.42%
1.18M
2.07%
1.63M
37.42%
3.05M
87.65%
1.87M
38.85%
total other income expenses net
225K
-
-38K
116.89%
-56K
47.37%
-88K
57.14%
-39K
55.68%
-377K
866.67%
71K
118.83%
-24K
133.80%
-818K
3,308.33%
-387K
52.69%
73K
118.86%
income before tax
-13.01M
-
-10.35M
20.43%
-6.87M
33.70%
-1.44M
78.99%
231K
116.02%
-1.84M
898.70%
409K
122.17%
583K
42.54%
-5.27M
1,003.43%
-7.31M
38.75%
4.63M
163.30%
income tax expense
127K
-
92K
27.56%
19K
79.35%
63K
231.58%
103K
63.49%
130K
26.21%
75K
42.31%
35K
53.33%
68K
94.29%
-32K
147.06%
-75K
134.38%
net income
-13.14M
-
-10.45M
20.50%
-6.88M
34.10%
-1.50M
78.14%
128K
108.50%
-1.98M
1,642.97%
334K
116.91%
548K
64.07%
-5.33M
1,073.54%
-7.28M
36.38%
4.70M
164.61%
weighted average shs out
8.70M
-
8.70M
0.03%
10.98M
26.16%
11.00M
0.19%
11.34M
3.06%
11.84M
4.44%
13.14M
10.94%
13.20M
0.44%
13.54M
2.61%
13.55M
0.04%
13.66M
0.83%
weighted average shs out dil
8.70M
-
8.70M
0.03%
10.98M
26.16%
11.00M
0.19%
14.10M
28.11%
11.84M
15.98%
14.57M
23.05%
14.16M
2.84%
13.54M
4.37%
13.55M
0.04%
14.27M
5.31%
eps
-1.51
-
-1.20
20.53%
-0.63
47.50%
-0.14
77.78%
0.01
108.07%
-0.17
1,604.42%
0.03
117.65%
0.04
33.33%
-0.39
1,075%
-0.54
38.46%
0.34
162.96%
epsdiluted
-1.51
-
-1.20
20.53%
-0.63
47.50%
-0.14
77.78%
0.01
106.50%
-0.17
1,968.13%
0.02
111.76%
0.04
100%
-0.39
1,075%
-0.54
38.46%
0.33
161.11%

All numbers in USD (except ratios and percentages)